肝纤维化早期的无创性诊断方法最新研究进展
The Latest Research Progress of Invasive Diagnosis in the Early Stage of Liver Fibrosis
DOI: 10.12677/jcpm.2024.34390, PDF,    科研立项经费支持
作者: 徐 多, 庄 坤*：西安市中心医院消化内科，陕西 西安
关键词: 肝纤维化；血清学标志物；影像学；人工智能；肝硬化；诊断；Liver Fibrosis； Serum Marker； Imageology； Artificial Intelligence； Liver Cirrhosis； Diagnosis
摘要: 肝纤维化是慢性肝脏疾病进展过程中非常关键的一个阶段，因其具有可逆性，因此早期诊断肝纤维化对于日后临床治疗以及患者预后具有重要意义。但诊断肝纤维化金标准是肝脏活检，因其有创等缺点不适合随着时间动态演变监测病情变化，因此本文通过血清学标志物、影像学手段、人工智能等方面对于针对肝纤维化早期阶段的诊断最新方法研究进展进行综述。
Abstract: Liver fibrosis is a very critical stage in the progression of chronic liver disease. Because of its reversibility, early diagnosis of liver fibrosis is of great significance for clinical treatment and prognosis of patients after chronic liver disease. However, the standard for the diagnosis of hepatic fibrosis is liver biopsy, and it is not suitable to monitor the changes in the disease dynamically over time because of its invasiveness and other shortcomings. Therefore, this article reviews the research progress of the latest methods for the diagnosis of early stage of liver fibrosis through serum markers, Imageology diagnosis, artificial intelligence and so on.
文章引用：徐多, 庄坤. 肝纤维化早期的无创性诊断方法最新研究进展[J]. 临床个性化医学, 2024, 3(4): 2752-2757. https://doi.org/10.12677/jcpm.2024.34390

参考文献

[1] Asrani, S.K., Devarbhavi, H., Eaton, J. and Kamath, P.S. (2019) Burden of Liver Diseases in the World. Journal of Hepatology, 70, 151-171. [Google Scholar] [CrossRef] [PubMed]
[2] Ginès, P., Krag, A., Abraldes, J.G., Solà, E., Fabrellas, N. and Kamath, P.S. (2021) Liver Cirrhosis. The Lancet, 398, 1359-1376. [Google Scholar] [CrossRef] [PubMed]
[3] Kisseleva, T. (2017) The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver. Hepatology, 65, 1039-1043. [Google Scholar] [CrossRef] [PubMed]
[4] Maroto-García, J., Moreno Álvarez, A., Sanz de Pedro, M.P., Buño-Soto, A. and González, Á. (2023) Serum Biomarkers for Liver Fibrosis Assessment. Advances in Laboratory Medicine/Avances en Medicina de Laboratorio, 5, 115-130. [Google Scholar] [CrossRef] [PubMed]
[5] (2015) Chikungunya Virus Infections. New England Journal of Medicine, 373, 93-95.
[6] Heyens, L.J.M., Busschots, D., Koek, G.H., Robaeys, G. and Francque, S. (2021) Liver Fibrosis in Non-Alcoholic Fatty Liver Disease: From Liver Biopsy to Non-Invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine, 8, Article 615978. [Google Scholar] [CrossRef] [PubMed]
[7] Oefner, C.M., Sharkey, A., Gardner, L., Critchley, H., Oyen, M. and Moffett, A. (2015) Collagen Type IV at the Fetal-Maternal Interface. Placenta, 36, 59-68. [Google Scholar] [CrossRef] [PubMed]
[8] Fu, X., Zhang, F., Zhen, F., Duan, L., Zhou, J. and Ma, J. (2024) A Chemiluminescence Immunoassay for Type IV Collagen as a Promising Marker for Liver Fibrosis and Cirrhosis. Analytical Methods, 16, 2248-2255. [Google Scholar] [CrossRef] [PubMed]
[9] Mak, K.M., Chen, L.L. and Lee, T. (2013) Codistribution of Collagen Type IV and Laminin in Liver Fibrosis of Elderly Cadavers: Immunohistochemical Marker of Perisinusoidal Basement Membrane Formation. The Anatomical Record, 296, 953-964. [Google Scholar] [CrossRef] [PubMed]
[10] Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W.T., et al. (2022) American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings. Endocrine Practice, 28, 528-562. [Google Scholar] [CrossRef] [PubMed]
[11] Itakura, J., Kurosaki, M., Setoyama, H., Simakami, T., Oza, N., Korenaga, M., et al. (2021) Applicability of APRI and FIB-4 as a Transition Indicator of Liver Fibrosis in Patients with Chronic Viral Hepatitis. Journal of Gastroenterology, 56, 470-478. [Google Scholar] [CrossRef] [PubMed]
[12] Bril, F., Leeming, D.J., Karsdal, M.A., Kalavalapalli, S., Barb, D., Lai, J., et al. (2019) Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes. Diabetes Care, 42, 1348-1351. [Google Scholar] [CrossRef] [PubMed]
[13] 魏莎, 陈晰, 章臻翊, 等. 肝纤维化的早期血清标志物研究进展[J]. 实用预防医学, 2024, 31(2): 252-257.
[14] Gabrielli, G.B., Capra, F., Casaril, M., Squarzoni, S., Tognella, P., Dagradi, R., et al. (1997) Serum Laminin and Type III Procollagen in Chronic Hepatitis C. Diagnostic Value in the Assessment of Disease Activity and Fibrosis. Clinica Chimica Acta, 265, 21-31. [Google Scholar] [CrossRef] [PubMed]
[15] Annoni, G., Colombo, M., Cantaluppi, M.C., Khlat, B., Lampertico, P. and Rojkind, M. (1989) Serum Type III Procollagen Peptide and Laminin (lam-P1) Detect Alcoholic Hepatitis in Chronic Alcohol Abusers. Hepatology, 9, 693-697. [Google Scholar] [CrossRef] [PubMed]
[16] Mosca, A., Comparcola, D., Romito, I., Mantovani, A., Nobili, V., Byrne, C.D., et al. (2019) Plasma N‐terminal Propeptide of Type III Procollagen Accurately Predicts Liver Fibrosis Severity in Children with Non‐alcoholic Fatty Liver Disease. Liver International, 39, 2317-2329. [Google Scholar] [CrossRef] [PubMed]
[17] Petrova, T., Pesic, J., Pardali, K., Gaestel, M. and Arthur, J.S.C. (2020) P38 MAPK Signalling Regulates Cytokine Production in IL-33 Stimulated Type 2 Innate Lymphoid Cells. Scientific Reports, 10, Article No. 3479. [Google Scholar] [CrossRef] [PubMed]
[18] Cayrol, C. and Girard, J. (2017) Interleukin‐33 (Il‐33): A Nuclear Cytokine from the Il‐1 Family. Immunological Reviews, 281, 154-168. [Google Scholar] [CrossRef] [PubMed]
[19] 朱海军, 闫琼琼, 陈巍, 等. 腹腔注射IL-33抗体对CCl4诱导小鼠肝纤维化发病的作用[J]. 国际免疫学杂志, 2019, 42(3): 290-295.
[20] Irvine, K.M., Okano, S., Patel, P.J., Horsfall, L.U., Williams, S., Russell, A., et al. (2021) Serum Matrix Metalloproteinase 7 (MMP7) Is a Biomarker of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Scientific Reports, 11, Article No. 2858. [Google Scholar] [CrossRef] [PubMed]
[21] Lachowski, D., Matellan, C., Gopal, S., Cortes, E., Robinson, B.K., Saiani, A., et al. (2022) Substrate Stiffness-Driven Membrane Tension Modulates Vesicular Trafficking via Caveolin-1. ACS Nano, 16, 4322-4337. [Google Scholar] [CrossRef] [PubMed]
[22] Cao, Q., Lu, X., Azad, B.B., Pomper, M., Smith, M., He, J., et al. (2020) Cis-4-[18F]Fluoro-L-Proline Molecular Imaging Experimental Liver Fibrosis. Frontiers in Molecular Biosciences, 7, Article No. 90. [Google Scholar] [CrossRef] [PubMed]
[23] Liu, T., Wang, X., Karsdal, M.A., Leeming, D.J. and Genovese, F. (2012) Molecular Serum Markers of Liver Fibrosis. Biomarker Insights, 7, 105-117. [Google Scholar] [CrossRef] [PubMed]
[24] Lv, J., Xu, Y., Xu, L. and Nie, L. (2021) Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-Enhanced Photoacoustic Imaging. Radiology, 300, 89-97. [Google Scholar] [CrossRef] [PubMed]
[25] Sultan, L.R., Grasso, V., Jose, J., Al-Hasani, M., Karmacharya, M.B. and Sehgal, C.M. (2024) Advanced Techniques for Liver Fibrosis Detection: Spectral Photoacoustic Imaging and Superpixel Photoacoustic Unmixing Analysis for Collagen Tracking. Sensors, 24, Article No. 4617. [Google Scholar] [CrossRef] [PubMed]
[26] Spira, D., Schulze, M., Sauter, A., Brodoefel, H., Brechtel, K., Claussen, C., et al. (2012) Volume Perfusion-CT of the Liver: Insights and Applications. European Journal of Radiology, 81, 1471-1478. [Google Scholar] [CrossRef] [PubMed]
[27] Thaiss, W.M., et al. (2019) Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. Academic Radiology, 26, 1174-1180. [Google Scholar] [CrossRef] [PubMed]
[28] Ronot, M., Asselah, T., Paradis, V., Michoux, N., Dorvillius, M., Baron, G., et al. (2010) Liver Fibrosis in Chronic Hepatitis C Virus Infection: Differentiating Minimal from Intermediate Fibrosis with Perfusion Ct. Radiology, 256, 135-142. [Google Scholar] [CrossRef] [PubMed]
[29] Suzuki, T., Yamada, A., Komatsu, D., Kurozumi, M., Fujinaga, Y., Ueda, K., et al. (2017) Evaluation of Splenic Perfusion and Spleen Size Using Dynamic Computed Tomography: Usefulness in Assessing Degree of Liver Fibrosis. Hepatology Research, 48, 87-93. [Google Scholar] [CrossRef] [PubMed]
[30] Hartl, J., Denzer, U., Ehlken, H., Zenouzi, R., Peiseler, M., Sebode, M., et al. (2016) Transient Elastography in Autoimmune Hepatitis: Timing Determines the Impact of Inflammation and Fibrosis. Journal of Hepatology, 65, 769-775. [Google Scholar] [CrossRef] [PubMed]
[31] Shen, Y., Wu, S., Wu, L., Wang, S., Chen, Y., Liu, L., et al. (2019) The Prognostic Role of Liver Stiffness in Patients with Chronic Liver Disease: A Systematic Review and Dose-Response Meta-Analysis. Hepatology International, 13, 560-572. [Google Scholar] [CrossRef] [PubMed]
[32] Yin, M., Talwalkar, J.A., Glaser, K.J., Venkatesh, S.K., Chen, J., Manduca, A., et al. (2011) Dynamic Postprandial Hepatic Stiffness Augmentation Assessed with MR Elastography in Patients with Chronic Liver Disease. American Journal of Roentgenology, 197, 64-70. [Google Scholar] [CrossRef] [PubMed]
[33] Ferraioli, G. and Roccarina, D. (2022) Update on the Role of Elastography in Liver Disease. Therapeutic Advances in Gastroenterology, 15, 1-12. [Google Scholar] [CrossRef] [PubMed]
[34] Barr, R.G., Wilson, S.R., Rubens, D., Garcia-Tsao, G. and Ferraioli, G. (2020) Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology, 296, 263-274. [Google Scholar] [CrossRef] [PubMed]
[35] Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., et al. (2021) EASL Clinical Practice Guidelines on Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis—2021 Update. Journal of Hepatology, 75, 659-689. [Google Scholar] [CrossRef] [PubMed]
[36] Dietrich, C., Bamber, J., Berzigotti, A., Bota, S., Cantisani, V., Castera, L., et al. (2017) EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (long Version). Ultraschall in der Medizin—European Journal of Ultrasound, 38, e16-e47. [Google Scholar] [CrossRef] [PubMed]
[37] Wu, L., Shen, Y. and Li, F. (2020) Non-Invasive Diagnosis of Liver Fibrosis: A Review of Current Imaging Modalities. Gastroenterología y Hepatología (English Edition), 43, 211-221. [Google Scholar] [CrossRef] 
[38] Dana, J., Venkatasamy, A., Saviano, A., Lupberger, J., Hoshida, Y., Vilgrain, V., et al. (2022) Conventional and Artificial Intelligence-Based Imaging for Biomarker Discovery in Chronic Liver Disease. Hepatology International, 16, 509-522. [Google Scholar] [CrossRef] [PubMed]
[39] Wang, K., Lu, X., Zhou, H., Gao, Y., Zheng, J., Tong, M., et al. (2018) Deep Learning Radiomics of Shear Wave Elastography Significantly Improved Diagnostic Performance for Assessing Liver Fibrosis in Chronic Hepatitis B: A Prospective Multicentre Study. Gut, 68, 729-741. [Google Scholar] [CrossRef] [PubMed]